The dental imaging spinout is set to launch technology that gives dental patients a real-time visual impression of ongoing tooth decay.
Calcivis, a UK-based dental imaging spinout from University of Dundee, today closed a round of undisclosed size from investors including Scottish Investment Bank (SIB), the investment arm of government-owned economic development agency Scottish Enterprise.
SIB was joined by local angel syndicate Archangels and investment firm Julz.
Calcivis has built a dental imaging system to give patients a real-time visual impression of tooth decay. The technology uses a photoprotein that espouses light as dental surfaces demineralise with the aim of convincing patients to follow treatment plans prescribed by their dentist.
The spinout is reportedly based on work by Chris Longbottom, a senior lecturer in University of Dundee’s School of Dentistry who specialises in preventive and children’s dentistry, and Nigel Pitts, who once led Dundee’s Centre for Clinical Innovations.
The money will fund a UK release before the end of the year, once Calcivis has received regulatory clearance for European markets. Cash will also aid an application to US healthcare regulator Food and Drug Administration (FDA) ahead of a planned US launch in early 2019.
Calcivis has disclosed $9m in total, according to deals data PitchBook, including equity worth $3.9m in June 2015 from SIB, Archangels and undisclosed backers. SIB and Archangels had previously provided $1.35m in 2014.
Archangels also led a $1.9m round in 2012, to which SIB contributed $644,000.
